Search research articles
Contact Us
Filters
Showing results (151-160 of 176) with videos related to
Page
of 18
Sort By:
Blood Advances
|
June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
Roni Tamari, Michael Scordo, Binni M Kunvarjee, et al.
Blood Advances
|
November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation
Madhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.
The Lancet. Haematology
|
December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study
Michael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.
Transplantation and Cellular Therapy
|
April 13, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations
Moataz Ellithi, Sandeep Raj, Maria Bromberg, et al.
Transplantation and Cellular Therapy
|
May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
Corrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Bone Marrow Transplantation
|
July 23, 2020
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation
Richard J Lin, Raymond E Baser, Theresa A Elko, et al.
Blood Advances
|
December 8, 2020
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
Juliet N Barker, Sean M Devlin, Kristine A Naputo, et al.
JAMA Network Open
|
May 5, 2026
Hematopoietic Cell Transplant Access and Patient Diversity
Rachel Cusatis, Jianqun Kou, Caitrin Bupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
Transplantation and Cellular Therapy
|
December 30, 2022
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 176) with videos related to
Sort By:
Page
of 18
Blood Advances
|
June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
Roni Tamari, Michael Scordo, Binni M Kunvarjee, et al.
Blood Advances
|
November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation
Madhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.
The Lancet. Haematology
|
December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study
Michael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.
Transplantation and Cellular Therapy
|
April 13, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations
Moataz Ellithi, Sandeep Raj, Maria Bromberg, et al.
Transplantation and Cellular Therapy
|
May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
Corrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Bone Marrow Transplantation
|
July 23, 2020
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation
Richard J Lin, Raymond E Baser, Theresa A Elko, et al.
Blood Advances
|
December 8, 2020
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
Juliet N Barker, Sean M Devlin, Kristine A Naputo, et al.
JAMA Network Open
|
May 5, 2026
Hematopoietic Cell Transplant Access and Patient Diversity
Rachel Cusatis, Jianqun Kou, Caitrin Bupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
Transplantation and Cellular Therapy
|
December 30, 2022
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Page
of 18